TABLE 3.
CDR loop | Gene usage | TCR residue | Peptide residue | MHC residue | vdW (≤4 Å) | H-bonds (≤3.4 Å) |
---|---|---|---|---|---|---|
CDR1α | TRAV22 | Asp-27Oδ2 | Thr-163Oγ1 | 4 | 1 | |
TRAV22 | Asp-27Oδ1 | Glu-166Oϵ2 | 2 | 1 | ||
TRAV22 | Ser-28 | Ala-158 | 1 | |||
TRAV22 | Val-29 | Gln-155 | 4 | |||
TRAV22 | Val-29 | Lys-4 | 4 | |||
TRAV22 | Asn-30 | Gln-155 | 1 | |||
CDR2α | TRAV22 | Tyr-48 | Glu-154 | 1 | ||
TRAV22 | Tyr-48 | Gln-155 | 2 | |||
TRAV22 | Ser-51O | Glu-154Oδ | 1 | 1 | ||
TRAV22 | Ser-51 | Arg-157 | 1 | |||
TRAV22 | Gln-55Oϵ1 | Glu-154Oϵ2 | 1 | |||
FWα | TRAV22 | Arg-68NH1/NH2 | Glu-166Oϵ1/Oϵ2 | 4 | 2 salt bridges | |
CDR3α | TRAJ40 | Asp-91Oδ1 | Lys-4Nζ | 3 | 1 salt bridge | |
TRAJ40 | Ser-92O | Lys-4Nζ | 2 | 1 | ||
TRAJ40 | Ala-93 | Lys-66 | 1 | |||
TRAJ40 | Ala-93 | Thr-163 | 2 | |||
TRAJ40 | Ala-93 | Lys-4 | 2 | |||
TRAJ40 | Thr-94O | Lys-66Nζ | 3 | 1 | ||
TRAJ40 | Thr-94 | Trp-167 | 3 | |||
TRAJ40 | Ser-95 | Lys-4 | 4 | |||
TRAJ40 | Gly-96 | Arg-65 | 3 | |||
TRAJ40 | Thr-97O | Lys-4Nζ | 3 | 1 | ||
TRAJ40 | Tyr-98 | Lys-66 | 3 | |||
TRAJ40 | Tyr-98 | Ala-69 | 2 | |||
TRAJ40 | Tyr-98 | Lys-4 | 2 | |||
TRAJ40 | Tyr-98 | Leu-6 | 4 | |||
CDR1β | TRBV6 | Glu-30 | Trp-8 | 13 | ||
CDR2β | TRBV6 | Val-50 | Val-152 | 1 | ||
TRBV6 | Val-50 | Leu-6 | 1 | |||
TRBV6 | Val-50 | Trp-8 | 1 | |||
TRBV6 | Ile-54 | Gln-72 | 4 | |||
CDR3β | TRBJ1-1 | Tyr-95 | Lys-146 | 5 | ||
TRBJ1-1 | Tyr-95 | Ala-150 | 2 | |||
TRBJ1-1 | Gln-96 | Lys-146 | 2 | |||
TRBJ1-1 | Gln-96Oϵ1 | Trp-147Nϵ1 | 4 | 1 | ||
TRBJ1-1 | Gln-96 | Ala-150 | 1 | |||
TRBJ1-1 | Gln-96 | Val-152 | 1 | |||
TRBJ1-1 | Gln-96 | Leu-6 | 2 | |||
TRBJ1-1 | Gln-96 | His-7 | 3 | |||
TRBJ1-1 | Gln-96Oϵ1 | Trp-8N/O | 5 | 2 |